4Vote!
PR News Wire (Free subscription) | 11/23/2009
SEATTLE, Nov. 23 /PRNewswire/ -- Immune Design Corp. (IDC) announced today that Dr. Bruce L.A. Carter has joined IDC as Executive Chairman. Dr. Carter has a successful track record in biotechnology executive management. He was the former Chief Executive Officer at ZymoGenetics, in Seattle, WA and Chief Scientific Officer at Novo Nordisk, Copenhagen, Denmark.
4Vote!
JJS Diabetes (Free subscription) | 11/21/2009
First, we'd like any of our patients to honestly inform us if they believe we have been spending less time with them in the recent past. It has not been planned to do so to date, but, it may come to that if some changes are not made. Almost one-third of doctors in an industry-sponsored survey said they didn't spend enough time with their diabetic patients and blamed low reimbursement rates for diabetes...
3Vote!
Mulled Whines (Free subscription) | 11/18/2009
I don't know about you, but when I fancy a little something between meals, there's only one thing I do... Which explains why I've spent the day eating chocolate gateau and Quality Street with a load of diabetes experts. There were cream cakes too, but you have to draw the line somewhere. Needless to say, if you're going to overdose on sugar, the one place you want to do it is at the national headquarters...
5Vote!
Market Wire (Free subscription) | 11/16/2009
BAGSVAERD, DENMARK (MARKET WIRE) On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
3Vote!
Hindu (Free subscription) | 11/15/2009
MADURAI: ‘Diabetes Walk’ was organised here on Saturday to mark the World Diabetes Day for creating public awareness about diabetes and its complications. Novo Nordisk, a leading company in diabetes care and insulin ...
4Vote!
The News Market (Free subscription) | 11/13/2009
The International Diabetes Federation (IDF) has once again called upon the diabetes community, including Novo Nordisk, to join forces and unite on the UN-observed World Diabetes Day on November 14 .
5Vote!
The Medical Quack (Free subscription) | 11/13/2009
The drug has been seeing a bit of success in Europe and the announcement was made it is at the final stage for approval from the FDA. BD Novo Nordisk’s CEO, Lars Sorensen, told Reuters at the Reuters Health Summit in New York that the new diabetes drug Victoza has reached the final decision stage at the U.S. FDA. Sorensen expects the drug will be approved, although “potentially all the...
3Vote!
Medical News Today (Free subscription) | 11/12/2009
Novo Nordisk cannounced that it would extend the Changing Diabetes® in Children programme to include Bangladesh. This is the sixth country to get diabetes care, including free insulin, for children with type 1 diabetes under this programme.
6Vote!
PharmaGossip (Free subscription) | 11/12/2009
Novo Nordisk cuts hundreds of jobs Published 11.11.09 13:20 Nation’s leading pharmaceutical company’s closing of production plant in Kalundborg affects over 300 jobs Pharmaceutical company Novo Nordisk is shutting down one of its insulin-producing facilities in the Zealand town of Kalundborg, a move that will result in 330 positions... --> According to the company, 100 employees will...
4Vote!
Diet and Weight Loss News (Free subscription) | 11/11/2009
The drug, liraglutide, is the first of a new class of anti-obesity agents which mimic the action of a hormone that occurs naturally in the gut, reducing hunger. Experts said it had "great potential" because it also reduced the risk factors for Type 2 diabetes and heart disease. Diabetes already affects more than two million people in Britain and is rising so fast it threatens to overwhelm...
7Vote!
Patently-O: Patent Law Blog (Free subscription) | 11/08/2009
Novo Nordisk v. Caraco Pharma (Fed. Cir. 2009) Unlike most interlocutory orders, the grant or denial of preliminary injunctive relief may be immediately appealed. A district court only awards preliminary injunctive relief after determining that the moving party is likely...
6Vote!
BloggingStocks (Free subscription) | 10/30/2009
Filed under: Earnings reports , Allergan (AGN) One would expect generic U.S. drugmaker Mylan (NYSE: MYL ) to benefit from all this talk about increased generic competitions, but revenue only increased 5.2 percent to $1.26 billion on an operational basis, beating analyst revenue estimates of $1.23 billion. Still, revenue in North America, where most pharmas have been hurting, rose 9.2 percent to $502.5...
6Vote!
Market Wire (Free subscription) | 10/30/2009
BAGSVAERD, DENMARK (MARKET WIRE) Trading in Novo Nordisk shares by board members, executives and associated persons as reported to Novo Nordisk on 29 October 2009
5Vote!
PR News Wire (Free subscription) | 10/30/2009
PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced the re-launch of its changing possibilities in hemophilia(TM) campaign through a rebranded Web site and a new community on Facebook®. People living with hemophilia face many daily challenges, and Novo Nordisk is committed to helping this community realize that there is also a lifetime of possibilities.
Videos